Transaction #16552 · Form 4 · 0000912282-25-001370
IRulya Therapeutics Inc. · Exercise / conversion · Common Shares
IRulya Therapeutics Inc. · Transacted December 5, 2025 · Filed December 8, 2025
What does this filing report?
An SEC Form 4 filing for IRulya Therapeutics Inc. records an exercise / conversion involving Common Shares on December 5, 2025. The reported quantity was 2,271. The filing date is December 8, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- IRulya Therapeutics Inc.
- Company CIK
- 0001662774
- Security type
- Non-derivative
- Acquisition type
- Exercise / conversion · Code M
- Quantity acquired
- 2,271
- Reported price
- 0.55
- Reference value
- 1,249.05
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 336,547
- Ownership description
- Not reported
- SEC acceptance time
- Dec 8, 2025, 8:12 AM EST
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- Hannah Brendan ↗
CBO, COO & CCO
CIK 0001929422
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
This transaction is not mapped to a specific company listing.
Filing footnotes & remarks
- F1
- Represents grant of 103,500 employee stock options on May 19, 2022, which vest over a four-year period, with 25% of the shares subject to the option vesting on the first anniversary of the vesting commencement date and the remainder vesting in 36 equal monthly installments over the following three years.
- F2
- Represents grant of 225,000 employee stock options on February 2, 2023, which vest in equal monthly installments at a rate of 1/48th of the total number of shares on each monthly anniversary of the vesting commencement date of January 1, 2023, with full vesting on the fourth annual anniversary of the vesting commencement date.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.